ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: NCCR Presents Gold Medal To Sen. Karkin; DCT Recruits Okunieff For Radiation Oncology

February 26, 1993

First Mobil NMR Scanner Goes Into Operation At Temple

June 22, 1984

Oncotype DX Cancer Test Can Predict Recurrence

November 25, 2011

Peters Replaced As Director Of Karmanos Cancer Center.

December 1, 2000

DeVita Frustrated By Gap Between Bypass, “Real” Budgets, Seeks Better System To Develop Priorites

April 24, 1981

Komen, ACS Support Payment Off-Protocol; Dilemma for Advocates

April 16, 1999